Molecular targets for breast cancer therapy and prevention

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Nature Medicine

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/87872PMID 11329054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy

  2004cited by this paper
• Role of Retinoid Receptors in the Prevention and Treatment of Breast Cancer

  2004cited by this paper
• Adjuvant therapy in breast cancer.

  2002cited by this paper
• The n e w e n g l a n d j o u r n a l of m e d i c i n e

  2001cited by this paper
• Clinical trials of Herceptin(trastuzumab).

  2001cited by this paper
• Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

  2001cited by this paper
• Cyclin D1 Is Required for Transformation by Activated Neu and Is Induced through an E2F-Dependent Signaling Pathway

  2000cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• The mammary gland iodide transporter is expressed during lactation and in breast cancer

  2000cited by this paper
• Inhibition of HER 2 / neu ( erb B-2 ) and Mitogen-activated Protein Kinases Enhances Tamoxifen Action against HER 2-overexpressing , Tamoxifen-resistant Breast Cancer Cells 1

  2000cited by this paper
• Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition.

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.

  2000cited by this paper
• Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor.

  2000cited by this paper
• Mutations truncating the EP300 acetylase in human cancers

  2000cited by this paper
• The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis

  2000cited by this paper
• Inhibition of CDKs as a Therapeutic Modality

  2000cited by this paper
• Tumor angiogenesis: past, present and the near future.

  2000cited by this paper
• Suberoylanilide Hydroxamic Acid as a Potential Therapeutic Agent for Human Breast Cancer Treatment

  2000cited by this paper
• Fenretinide and cancer prevention

  2000cited by this paper
• Breast cancer chemoprevention.

  2000cited by this paper
• Combinatorial chemoprevention of intestinal neoplasia

  2000cited by this paper
• Preclinical and clinical development of cyclin-dependent kinase modulators.

  2000cited by this paper
• Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor

  2000cited by this paper
• High constant incidence in twins and other relatives of women with breast cancer

  2000cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis

  2000cited by this paper
• Adjuvant therapy for breast cancer.

  2000cited by this paper
• Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.

  2000cited by this paper
• ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics.

  2000cited by this paper
• Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo.

  2000cited by this paper
• Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

  2000cited by this paper
• Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.

  2000cited by this paper
• Developments in chemotherapy of breast cancer

  2000cited by this paper
• Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.

  1999cited by this paper
• Regulation of Cyclooxygenase-2 pathway by HER2 receptor

  1999cited by this paper
• Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

  1999cited by this paper
• The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation.

  1999cited by this paper
• Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

  1999cited by this paper
• SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

  1999cited by this paper
• Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer

  1999cited by this paper
• Angiogenic growth factors in preinvasive breast disease.

  1999cited by this paper
• Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).

  1999cited by this paper
• erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer.

  1998cited by this paper
• Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers.

  1998cited by this paper
• Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.

  1998cited by this paper
• Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.

  1998cited by this paper
• No significant predictive value of c‐ erbB‐2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

  1998cited by this paper
• p53-independent apoptosis induced by paclitaxel through an indirect mechanism.

  1997cited by this paper
• Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

  1997cited by this paper
• Annual hazard rates of recurrence for breast cancer after primary therapy.

  1996cited by this paper
• Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.

  1995cited by this paper
• Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.

  1995cited by this paper
• Oncogene amplification and prognosis in breast cancer: relationship with systemic treatment.

  1995cited by this paper
• The biology of erbB-2/neu/HER-2 and its role in cancer.

  1994cited by this paper
• ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer.

  1994cited by this paper
• Breast cancer response to adjuvant chemotherapy in correlation with erbB2 and p53 expression.

  1994cited by this paper
• Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

  1994cited by this paper
• Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.

  1992cited by this paper
• Breast cancer chemoprevention.

  1992cited by this paper
• Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.

  1992cited by this paper
• Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

  1992cited by this paper
• A Hitchhiker’s Guide to the NIEHS Strategic Plan

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

  1985cited by this paper
• Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

  1984cited by this paper
• Single and combination nonhormonal chemotherapy in breast cancer

  1972cited by this paper

• Advances in DNA-based proteolysis-targeting chimeras technology: Novel strategies for targeting previously undruggable proteins in cancer therapy.

  2025cites this paper
• Combinatorial prediction of therapeutic perturbations using causally inspired neural networks.

  2025cites this paper
• Rapid sorting and auxiliary evaluation of malignant breast tumors by accurate imaging analysis of metastasis-related biomarker

  2025cites this paper
• Combinatorial prediction of therapeutic perturbations using causally-inspired neural networks

  2024cites this paper
• Enhancing RNA detection and breast cancer subtyping with a universal 3D-hybridization chain reaction system.

  2024cites this paper
• M1 macrophages polarized by crude polysaccharides isolated from Auricularia polytricha exhibit anti-tumor effect on human breast cancer cells

  2024cites this paper
• Therapeutic potential of hesperidin: Apoptosis induction in breast cancer cell lines.

  2023cites this paper
• An enzyme-powered microRNA discriminator for the subtype-specific diagnosis of breast cancer

  2023cites this paper
• Molecular dynamics study of Quercetin families and its derivative compounds from Carica papaya leaf as breast cancer inhibitors

  2022cites this paper
• Remarkable anticancer activity and molecular docking studies of ferrocene tethered pyrimidobenzothiazoles and pyrimidobenzimidazoles

  2022cites this paper
• Molecular Characterization of Exosomes for Subtype-Based Diagnosis of Breast Cancer.

  2022cites this paper
• Extrachromosomal circular DNA: biogenesis, structure, functions and diseases

  2022cites this paper
• Fibroblast-derived conditioned media promotes lung cancer progression.

  2022cites this paper
• Recent Advances In Breast Cancer Treatments

  2022cites this paper
• Harnessing the Immunogenic Potential of Gold Nanoparticle-Based Platforms as a Therapeutic Strategy in Breast Cancer Immunotherapy: A Mini Review

  2022cites this paper
• Trends in iron oxide nanoparticles: a nano-platform for theranostic application in breast cancer

  2022cites this paper
• Comparison with molecular effects of ukrain, tamoxifen, and docetaxel on human breast cancer cell lines

  2022cites this paper
• Rottlerin promotes anti-metastatic events by ameliorating pharmacological parameters of paclitaxel: An in-vivo investigation in the orthotopic mouse model of breast cancer.

  2022cites this paper
• A New Insight for the Identification of Oncogenic Variants in Breast and Prostate Cancers in Diverse Human Populations, With a Focus on Latinos

  2021cites this paper
• Recent Advances Toward Development of Plant Cell Culture Process for Sustainable Production of Lignans and Their Health Benefits

  2021cites this paper
• Radionuclide-Based Imaging of Breast Cancer: State of the Art

  2021influential citation
• Selective and predicable amine conjugation sites by kinetic characterization under excess reagents

  2021cites this paper
• Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems

  2021cites this paper
• Targeted combined therapy in 2D and 3D cultured MCF-7 cells using metformin and erlotinib-loaded mesoporous silica magnetic nanoparticles

  2021cites this paper
• The Emerging Role of the Mammalian Glycocalyx in Functional Membrane Organization and Immune System Regulation

  2020influential citation
• Applications of Antibodies in Therapy, Diagnosis, and Science

  2020cites this paper
• Expression of MicroRNA-155 and Suppressor of Cytokines Signaling 1 (SOCS1) mRNA in Plasma Breast Cancer Patients

  2020cites this paper
• A Review on Targeted Cell Therapy for Breast Cancer, Colon Cancer and Lung Cancer

  2020cites this paper
• Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer.

  2020cites this paper
• 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation

  2020cites this paper
• Tissue Engineering Models for the Study of Breast Neoplastic Disease and the Tumor Microenvironment

  2020cites this paper
• PD-L1/PD-1 axis as a potent therapeutic target in breast cancer.

  2020cites this paper
• DIOSCIN INDUCES APOPTOSIS IN BREAST CANCER CELL LINES THROUGH MITOCHONDRIAL SIGNALING PATHWAY Yogaraj

  2020cites this paper
• Cytotoxic, anti-proliferative and apoptotic effects of noscapine on human estrogen receptor positive (MCF-7) and negative (MDA-MB-231) breast cancer cell lines.

  2020cites this paper
• Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma

  2019cites this paper
• An oligonucleotide probe incorporating the chromophore of green fluorescent protein is useful for the detection of HER-2 mRNA breast cancer marker.

  2019cites this paper
• Effect of recombinant Herceptin on the growth of breast cancer cells

  2019cites this paper
• Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies

  2019cites this paper
• Integration of in vitro and in silico perspectives to explain chemical characterization, biological potential and anticancer effects of Hypericum salsugineum: A pharmacologically active source for functional drug formulations

  2018cites this paper
• Pneumonitis after precision oncology therapies: A concise review

  2018cites this paper
• Investigating the potential of tetrahydropyridinyl chalcones as useful agents against breast carcinoma: An in vitro and in vivo study

  2018cites this paper
• Particularisation to an Individual

  2018cites this paper
• Effects of RSF-1 on proliferation and apoptosis of breast cancer cells

  2018cites this paper
• Age-related host factors regulate lung cancer progression.

  2017cites this paper
• The Dawning of Translational Breast Cancer: From Bench to Bedside.

  2017cites this paper
• MANOTA: a promising bifunctional chelating agent for copper-64 immunoPET.

  2017cites this paper
• Design, synthesis, and biological evaluation of steroidal analogs as estrogenic/anti-estrogenic agents

  2017cites this paper
• Regulation of Net 1 A subcellular localization by the small GTPase Rac 1

  2017cites this paper
• Management of Chemotherapy-Associated Cardiomyopathy

  2017cites this paper
• Multitargeted Molecular Docking Study of Natural-Derived Alkaloids on Breast Cancer Pathway Components.

  2017cites this paper
• Inducing Polyclonal Eag1-Specific Antibodies by Vaccination with a Linear Epitope Immunogen and Its Relation to Breast Tumorigenesis

  2017cites this paper
• LC-MS/MS-Based Monitoring of In Vivo Protein Biotransformation: Quantitative Determination of Trastuzumab and Its Deamidation Products in Human Plasma.

  2016cites this paper
• Synthesis, Characterization and In–vitro Evaluation of Anticancer Potential of Chitosan–coated Polyoxometalates Nanoparticles

  2016cites this paper
• Preparation and In Vitro Evaluation of Antitumor Activity of TGFαL3-SEB as a Ligand-Targeted Superantigen

  2016cites this paper
• Bacterial Effector Nanoparticles as Breast Cancer Therapeutics.

  2016cites this paper
• The long range regulation of breast cancer associated genes

  2016cites this paper
• Decreased sirtuin 4 expression is associated with poor prognosis in patients with invasive breast cancer

  2016cites this paper
• Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides

  2016cites this paper
• Low doses of paclitaxel enhance liver metastasis of breast cancer cells in the mouse model

  2016cites this paper
• The role of Plk3 in oncogenesis

  2016cites this paper
• Development of an enzymatic pretargeting strategy for dual-modality imaging.

  2015cites this paper
• Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms

  2015cites this paper
• Targeting HER2 Positive Breast Cancer with Chemopreventive Agents

  2015cites this paper
• Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK Pathway

  2015cites this paper
• Sphingolipids as Mediators of Breast Cancer Progression, Metastasis, Response and Resistance to Chemotherapy

  2015cites this paper
• Bridging academic science and clinical research in the search for novel targeted anti-cancer agents

  2015cites this paper
• Etude de la toxicité des nanoparticules d'oxyde de fer (Fe3O4) chez le rat : analyses mitochondriales et du stress oxydant

  2015cites this paper
• Synthesis of 3-aroyl-4-aryl-1-isopropylamino-4-piperidinols and evaluation of the cytotoxicities of the compounds against human hepatoma and breast cancer cell lines

  2015cites this paper
• Inhibitory Effect of Shiitake Mushroom Extracts Cultured in Aloe-Supplement on Invasion/Migration of TNF-α-Induced MDA-MB-231 Breast Cancer Cells

  2015cites this paper
• A pan-cancer analysis of prognostic genes

  2015cites this paper
• Pleurotus eous polysaccharides suppress angiogenesis and induce apoptosis via ROS-dependent JNK activation and mitochondrial mediated mechanisms in MCF-7 human breast cancer cells

  2015cites this paper
• The biological properties evaluation of the radiolabeled complex: 99mTc -DTPA- Herceptin in cancerous cell lines

  2015cites this paper
• Targeted cancer therapy; nanotechnology approaches for overcoming drug resistance.

  2015cites this paper
• Hyaluronidase-incorporated hyaluronic acid-tyramine hydrogels for the sustained release of trastuzumab.

  2015cites this paper
• Synthesis, molecular modeling, and biological evaluation of quinazoline derivatives containing the 1,3,4-oxadiazole scaffold as novel inhibitors of VEGFR2

  2015cites this paper
• Cancer Vaccine Final IQP

  2015cites this paper
• Synthesis and properties of an efficient tumor cells-interacting fluorescent probe derived from rhodamine B

  2014cites this paper
• Exome-driven characterization of the cancer cell lines at the proteome level: the NCI-60 case study.

  2014cites this paper
• Synthesis of new N,N′-bis[1-aryl-3-(piperidine-1-yl)propylidene]hydrazine dihydrochlorides and evaluation of their cytotoxicity against human hepatoma and breast cancer cells

  2014cites this paper
• Somatic alterations as the basis for resistance to targeted therapies

  2014cites this paper
• Identification of Disulfiram as a Potential Therapeutic for RB1 -proficient and -deficient Triple Negative Breast Cancer

  2014cites this paper
• Iridoid glycosides-Kutkin, Picroside I, and Kutkoside from Picrorrhiza kurroa Benth inhibits the invasion and migration of MCF-7 breast cancer cells through the down regulation of matrix metalloproteinases

  2013cites this paper
• Immunotherapeutic strategies to target prognostic and predictive markers of cancer.

  2013cites this paper
• A Time Travel Journey Through Cancer Therapies

  2013cites this paper
• Phosphatase Modulators

  2013cites this paper
• Targeted cancer therapies: the future of cancer treatment.

  2013cites this paper
• Protein tyrosine phosphatases: structure, function, and implication in human disease.

  2013cites this paper
• Protective role of lignan-converting bacteria on chemically- induced breast cancer in gnotobiotic rats

  2013cites this paper
• Dissecting GRB7-mediated signals for proliferation and migration in HER2 overexpressing breast tumor cells: GTP-ase rules.

  2013cites this paper
• Characterization of aberrant pathways across human cancers

  2013cites this paper
• Monoclonal Antibodies Targeting EGFR/HER2 and Clinical Outcomes in Cancer Treatment

  2013cites this paper
• A COMPARISON BETWEEN OESTROGEN AND HER-2 IMMUNOHISTOCHEMICAL STAINING OF CORE AND EXCISION BIOPSY SPECIMENS IN BREAST CANCER

  2013cites this paper
• Preparation of gold nanocluster bioconjugates for electron microscopy.

  2013cites this paper
• Dissecting GRB 7-mediated signals for proliferation and migration in HER 2 overexpressing breast tumor cells : GTPase rules

  2013cites this paper
• Update on clinical trials: genetic targets in breast cancer.

  2013cites this paper
• Alpha Cyano-4-Hydroxy-3-Methoxycinnamic Acid Inhibits Proliferation and Induces Apoptosis in Human Breast Cancer Cells

  2013cites this paper
• The in vivo Therapeutic Effect of Free Wanderer Powder (逍 遙 散 xiāo yáo sǎn, Xiaoyaosan) on Mice with 4T1 Cell Induced Breast Cancer Model

  2012cites this paper
• Quinuclidinone derivative 6 induced apoptosis in human breast cancer cells via sphingomyelinase and JNK signaling

  2012cites this paper
• Potential of PET to Predict the Response to Trastuzumab Treatment in an ErbB2-Positive Human Xenograft Tumor Model

  2012cites this paper
• Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells.

  2012cites this paper